Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 14, 2007
J Am Soc Nephrol 18: 913-922, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006070767

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006070767v1
18/3/913    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varghese, S. A.
Right arrow Articles by Arthur, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varghese, S. A.
Right arrow Articles by Arthur, J. M.

Clinical Nephrology

Urine Biomarkers Predict the Cause of Glomerular Disease

Sanju A. Varghese*, T. Brian Powell*, Milos N. Budisavljevic*,{dagger}, Jim C. Oates*, John R. Raymond*,{ddagger}, Jonas S. Almeida{ddagger} and John M. Arthur*,{dagger}

* Department of Medicine, Medical University of South Carolina, and {dagger} Department of Medicine, Ralph H. Johnson VA Medical Center, Charleston, South Carolina; and {ddagger} Department of Biostatistics and Applied Mathematics, University of Texas MD Anderson Cancer Center, Houston, Texas

Address correspondence to: Dr. John M. Arthur, Department of Medicine, Division of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas Street, P.O. Box 250623, Charleston, SC 29425. Phone: 843-792-4123; Fax: 843-792-8399; E-mail: arthurj{at}musc.edu

Received for publication July 21, 2006. Accepted for publication December 26, 2006.

Diagnosis of the type of glomerular disease that causes the nephrotic syndrome is necessary for appropriate treatment and typically requires a renal biopsy. The goal of this study was to identify candidate protein biomarkers to diagnose glomerular diseases. Proteomic methods and informatic analysis were used to identify patterns of urine proteins that are characteristic of the diseases. Urine proteins were separated by two-dimensional electrophoresis in 32 patients with FSGS, lupus nephritis, membranous nephropathy, or diabetic nephropathy. Protein abundances from 16 patients were used to train an artificial neural network to create a prediction algorithm. The remaining 16 patients were used as an external validation set to test the accuracy of the prediction algorithm. In the validation set, the model predicted the presence of the diseases with sensitivities between 75 and 86% and specificities from 92 to 67%. The probability of obtaining these results in the novel set by chance is 5 x 10–8. Twenty-one gel spots were most important for the differentiation of the diseases. The spots were cut from the gel, and 20 were identified by mass spectrometry as charge forms of 11 plasma proteins: Orosomucoid, transferrin, {alpha}-1 microglobulin, zinc {alpha}-2 glycoprotein, {alpha}-1 antitrypsin, complement factor B, haptoglobin, transthyretin, plasma retinol binding protein, albumin, and hemopexin. These data show that diseases that cause nephrotic syndrome change glomerular protein permeability in characteristic patterns. The fingerprint of urine protein charge forms identifies the glomerular disease. The identified proteins are candidate biomarkers that can be tested in assays that are more amenable to clinical testing.




This article has been cited by other articles:


Home page
CJASNHome page
B. H. Rovin and X. Zhang
Biomarkers for Lupus Nephritis: The Quest Continues
Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1858 - 1865.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
K. Bramham, H.D. Mistry, L. Poston, L.C. Chappell, and A.J. Thompson
The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?
QJM, August 1, 2009; 102(8): 523 - 538.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. A. Soler-Garcia, D. Johnson, Y. Hathout, and P. E. Ray
Iron-Related Proteins: Candidate Urine Biomarkers in Childhood HIV-Associated Renal Diseases
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. G. Miller, D. E. Bruns, G. L. Hortin, S. Sandberg, K. M. Aakre, M. J. McQueen, Y. Itoh, J. C. Lieske, D. W. Seccombe, G. Jones, et al.
Current Issues in Measurement and Reporting of Urinary Albumin Excretion
Clin. Chem., January 1, 2009; 55(1): 24 - 38.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Tangri, D. Ansell, and D. Naimark
Predicting technique survival in peritoneal dialysis patients: comparing artificial neural networks and logistic regression
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2972 - 2981.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Md. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad
Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein
Mol. Cancer Res., June 1, 2008; 6(6): 892 - 906.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H.-A. Shui, T.-H. Huang, S.-M. Ka, P.-H. Chen, Y.-F. Lin, and A. Chen
Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 176 - 185.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP